ADAM17 and ischemic stroke: ADAM17 activity did appear to be elevated in neutrophil cultures treated with serum obtained from ischemic stroke patients relative to those treated with serum obtained from both neurologically asymptomatic controls and stroke mimics, however this increase was not statistically significant (Fig. 3B).